Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
25.42
-0.96 (-3.64%)
At close: Mar 13, 2026, 4:00 PM EDT
25.35
-0.07 (-0.28%)
After-hours: Mar 13, 2026, 7:27 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.39 billion as of March 13, 2026. Its market cap has increased by 64.89% in one year.
Market Cap
1.39B
Enterprise Value
1.01B
1-Year Change
64.89%
Ranking
Category
Stock Price
$25.42
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.39B, an increase of 118.50%. That is a compound annual growth rate of 16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.65B | -8.40% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.80B |
| Enliven Therapeutics | 1.79B |
| Definium Therapeutics | 1.77B |
| Sarepta Therapeutics | 1.76B |
| Zymeworks | 1.75B |
| Iovance Biotherapeutics | 1.73B |
| Capricor Therapeutics | 1.72B |
| Recursion Pharmaceuticals | 1.71B |